Perfuze
Perfuze is developing innovative medical technology to treat acute ischemic stroke.
Total raised
€25M
€25,000,000
Funding rounds
2
Investors
6
distinct backers
Active since
2018-12
latest 2025-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood37
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 8y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-03-13 | Other | €22M | Earlybird,EQT Life Sciences,Existing investors,Seroba,SV Health Investors | View deal → |
| 2019-01-01 | Seed | €3.0M | EarlyBirdCapital | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech